CGTX
Price
$0.30
Change
+$0.01 (+3.45%)
Updated
Jun 6 closing price
Capitalization
18.31M
66 days until earnings call
MREO
Price
$2.74
Change
+$0.28 (+11.38%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
435.66M
123 days until earnings call
Interact to see
Advertisement

CGTX vs MREO

Header iconCGTX vs MREO Comparison
Open Charts CGTX vs MREOBanner chart's image
Cognition Therapeutics
Price$0.30
Change+$0.01 (+3.45%)
Volume$944.43K
Capitalization18.31M
Mereo BioPharma Group
Price$2.74
Change+$0.28 (+11.38%)
Volume$75.06K
Capitalization435.66M
CGTX vs MREO Comparison Chart
Loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGTX vs. MREO commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a Hold and MREO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CGTX: $0.30 vs. MREO: $2.74)
Brand notoriety: CGTX and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 75% vs. MREO: 148%
Market capitalization -- CGTX: $18.31M vs. MREO: $435.66M
CGTX [@Biotechnology] is valued at $18.31M. MREO’s [@Biotechnology] market capitalization is $435.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 1 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • CGTX’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than CGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 5 TA indicator(s) are bullish while MREO’s TA Score has 5 bullish TA indicator(s).

  • CGTX’s TA Score: 5 bullish, 5 bearish.
  • MREO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MREO is a better buy in the short-term than CGTX.

Price Growth

CGTX (@Biotechnology) experienced а +23.56% price change this week, while MREO (@Biotechnology) price change was +27.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CGTX is expected to report earnings on Aug 12, 2025.

MREO is expected to report earnings on Oct 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($436M) has a higher market cap than CGTX($18.3M). MREO YTD gains are higher at: -29.571 vs. CGTX (-57.892). CGTX has higher annual earnings (EBITDA): -33.03M vs. MREO (-43.41M). MREO has more cash in the bank: 80.5M vs. CGTX (16.4M). CGTX has less debt than MREO: CGTX (635K) vs MREO (6.68M). MREO has higher revenues than CGTX: MREO (1M) vs CGTX (0).
CGTXMREOCGTX / MREO
Capitalization18.3M436M4%
EBITDA-33.03M-43.41M76%
Gain YTD-57.892-29.571196%
P/E RatioN/AN/A-
Revenue01M-
Total Cash16.4M80.5M20%
Total Debt635K6.68M10%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXMREO
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 23 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRVRX17.25N/A
N/A
Nuveen Mid Cap Value Retire
BUFTX23.58N/A
N/A
Buffalo Mid Cap Discovery
FRUSX23.63N/A
N/A
Franklin Utilities C
EFCIX22.31N/A
N/A
Emerald Insights Institutional
TNRAX18.64N/A
N/A
1290 Avantis U.S. Large Cap Growth A

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and KYMR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and KYMR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
+1.79%
KYMR - CGTX
32%
Poorly correlated
-0.08%
CLDX - CGTX
31%
Poorly correlated
+9.32%
VTYX - CGTX
31%
Poorly correlated
+9.33%
VOR - CGTX
31%
Poorly correlated
+0.09%
MREO - CGTX
31%
Poorly correlated
+11.38%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-6.98%
CRNX - MREO
49%
Loosely correlated
+0.59%
TRDA - MREO
47%
Loosely correlated
+2.14%
KYMR - MREO
45%
Loosely correlated
+7.68%
VKTX - MREO
44%
Loosely correlated
+0.15%
KOD - MREO
44%
Loosely correlated
-1.26%
More